{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T03:16:54Z","timestamp":1791170214067,"version":"4.1.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,2]],"date-time":"2015-12-02T00:00:00Z","timestamp":1449014400000},"content-version":"vor","delay-in-days":1006,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Thoracic Oncology"],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1097\/jto.0b013e31827e1f83","type":"journal-article","created":{"date-parts":[[2013,2,12]],"date-time":"2013-02-12T07:05:06Z","timestamp":1360652706000},"page":"346-351","source":"Crossref","is-referenced-by-count":279,"title":["Local Therapy with Continued EGFR Tyrosine Kinase Inhibitor Therapy as a Treatment Strategy in EGFR-Mutant Advanced Lung Cancers That Have Developed Acquired Resistance to EGFR Tyrosine Kinase Inhibitors"],"prefix":"10.1016","volume":"8","author":[{"given":"Helena A.","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camelia S.","family":"Sima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen B.","family":"Solomon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Rimner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Paik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Catherine","family":"Pietanza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher G.","family":"Azzoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naiyer A.","family":"Rizvi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lee M.","family":"Krug","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent A.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark G.","family":"Kris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory J.","family":"Riely","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1097\/JTO.0b013e31827e1f83_bib1","doi-asserted-by":"crossref","first-page":"13306","DOI":"10.1073\/pnas.0405220101","article-title":"EGF receptor gene mutations are common in lung cancers from \u201cnever smokers\u201d and are associated with sensitivity of tumors to gefitinib and erlotinib","volume":"101","author":"Pao","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1097\/JTO.0b013e31827e1f83_bib2","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/nature05945","article-title":"Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer","volume":"448","author":"Soda","year":"2007","journal-title":"Nature"},{"key":"10.1097\/JTO.0b013e31827e1f83_bib3","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1016\/j.cell.2007.11.025","article-title":"Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer","volume":"131","author":"Rikova","year":"2007","journal-title":"Cell"},{"key":"10.1097\/JTO.0b013e31827e1f83_bib4","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/nm.2644","article-title":"KIF5B-RET fusions in lung adenocarcinoma","volume":"18","author":"Kohno","year":"2012","journal-title":"Nat Med"},{"key":"10.1097\/JTO.0b013e31827e1f83_bib5","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1056\/NEJMoa040938","article-title":"Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib","volume":"350","author":"Lynch","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1097\/JTO.0b013e31827e1f83_bib6","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1126\/science.1099314","article-title":"EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy","volume":"304","author":"Paez","year":"2004","journal-title":"Science"},{"key":"10.1097\/JTO.0b013e31827e1f83_bib7","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1056\/NEJMoa0810699","article-title":"Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma","volume":"361","author":"Mok","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1097\/JTO.0b013e31827e1f83_bib8","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S1470-2045(09)70364-X","article-title":"Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trial","volume":"11","author":"Mitsudomi","year":"2010","journal-title":"Lancet Oncol"},{"key":"10.1097\/JTO.0b013e31827e1f83_bib9","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1056\/NEJMoa0909530","article-title":"Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR","volume":"362","author":"Maemondo","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1097\/JTO.0b013e31827e1f83_bib10","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S1470-2045(11)70393-X","volume":"13","author":"Rosell","year":"2012","journal-title":"Lancet Oncol"},{"key":"10.1097\/JTO.0b013e31827e1f83_bib11","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/S1470-2045(12)70086-4","article-title":"Afatinib for patients with lung adenocarcinoma and epidermal growth factor receptor mutations (LUX-Lung 2): a phase 2 trial","volume":"13","author":"Yang","year":"2012","journal-title":"Lancet Oncol"},{"key":"10.1097\/JTO.0b013e31827e1f83_bib12","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1200\/JCO.2011.40.1315","article-title":"Randomized phase II trial of erlotinib alone or with carboplatin and paclitaxel in patients who were never or light former smokers with advanced lung adenocarcinoma: CALGB 30406 trial","volume":"30","author":"J\u00e4nne","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1097\/JTO.0b013e31827e1f83_bib13","doi-asserted-by":"crossref","first-page":"75ra26","DOI":"10.1126\/scitranslmed.3002003","article-title":"Genotypic and histological evolution of lung cancers acquiring resistance to EGFR inhibitors","volume":"3","author":"Sequist","year":"2011","journal-title":"Sci Transl Med"},{"key":"10.1097\/JTO.0b013e31827e1f83_bib14","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1056\/NEJMoa044238","article-title":"EGFR mutation and resistance of non-small-cell lung cancer to gefitinib","volume":"352","author":"Kobayashi","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1097\/JTO.0b013e31827e1f83_bib15","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1126\/science.1141478","article-title":"MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling","volume":"316","author":"Engelman","year":"2007","journal-title":"Science"},{"key":"10.1097\/JTO.0b013e31827e1f83_bib16","doi-asserted-by":"crossref","first-page":"20932","DOI":"10.1073\/pnas.0710370104","article-title":"MET amplification occurs with or without T790M mutations in EGFR mutant lung tumors with acquired resistance to gefitinib or erlotinib","volume":"104","author":"Bean","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1097\/JTO.0b013e31827e1f83_bib17","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1056\/NEJMc053610","article-title":"EGFR mutations in small-cell lung cancers in patients who have never smoked","volume":"355","author":"Zakowski","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1097\/JTO.0b013e31827e1f83_bib18","doi-asserted-by":"crossref","first-page":"90ra59","DOI":"10.1126\/scitranslmed.3002356","article-title":"Optimization of dosing for EGFR-mutant non-small cell lung cancer with evolutionary cancer modeling","volume":"3","author":"Chmielecki","year":"2011","journal-title":"Sci Transl Med"},{"key":"10.1097\/JTO.0b013e31827e1f83_bib19","doi-asserted-by":"crossref","first-page":"6298","DOI":"10.1158\/1078-0432.CCR-11-1468","article-title":"Disease flare after tyrosine kinase inhibitor discontinuation in patients with EGFR-mutant lung cancer and acquired resistance to erlotinib or gefitinib: implications for clinical trial design","volume":"17","author":"Chaft","year":"2011","journal-title":"Clin Cancer Res"},{"issue":"suppl; abstr 7524","key":"10.1097\/JTO.0b013e31827e1f83_bib20","article-title":"Chemotherapy with erlotinib or chemotherapy alone in advanced NSCLC with acquired resistance to EGFR tyrosine kinase inhibitors (TKI)","volume":"30","author":"Goldberg","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1097\/JTO.0b013e31827e1f83_bib21","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.thorsurg.2006.03.001","article-title":"Surgery for colorectal and sarcomatous pulmonary metastases: history, current management, and future directions","volume":"16","author":"Downey","year":"2006","journal-title":"Thorac Surg Clin"},{"key":"10.1097\/JTO.0b013e31827e1f83_bib22","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.ucl.2008.07.009","article-title":"Surgical intervention in patients with metastatic renal cancer: metastasectomy and cytoreductive nephrectomy","volume":"35","author":"Russo","year":"2008","journal-title":"Urol Clin North Am"},{"issue":"6 Suppl 2","key":"10.1097\/JTO.0b013e31827e1f83_bib26","doi-asserted-by":"crossref","first-page":"S172","DOI":"10.1097\/JTO.0b013e3181dca330","article-title":"Reported outcome factors for pulmonary resection in metastatic colorectal cancer","volume":"5","author":"Pfannschmidt","year":"2010","journal-title":"J Thorac Oncol"},{"key":"10.1097\/JTO.0b013e31827e1f83_bib27","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/j.1365-2354.2006.00717.x","article-title":"Factors causing early relapse after lung metastasis surgery","volume":"16","author":"R\u00edos","year":"2007","journal-title":"Eur J Cancer Care (Engl)"},{"key":"10.1097\/JTO.0b013e31827e1f83_bib28","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1093\/icvts\/ivr076","article-title":"Pulmonary metastasectomy: a multivariate analysis of 440 patients undergoing complete resection","volume":"14","author":"Younes","year":"2012","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"10.1097\/JTO.0b013e31827e1f83_bib29","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1097\/JTO.0b013e3182208e58","article-title":"A 10-year single-center experience on 708 lung metastasectomies: the evidence of the \u201cinternational registry of lung metastases\u201d","volume":"6","author":"Casiraghi","year":"2011","journal-title":"J Thorac Oncol"},{"key":"10.1097\/JTO.0b013e31827e1f83_bib30","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.lungcan.2005.02.012","article-title":"Adrenalectomy for solitary adrenal metastases from non-small cell lung cancer","volume":"49","author":"Pfannschmidt","year":"2005","journal-title":"Lung Cancer"},{"key":"10.1097\/JTO.0b013e31827e1f83_bib31","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.athoracsur.2004.06.051","article-title":"Lung cancer and its operable brain metastasis: survival rate and staging problems","volume":"79","author":"Fur\u00e1k","year":"2005","journal-title":"Ann Thorac Surg"},{"key":"10.1097\/JTO.0b013e31827e1f83_bib32","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1016\/j.ejcts.2009.11.025","article-title":"Surgical treatment of synchronous multiple lung cancer located in a different lobe or lung: high survival in node-negative subgroup","volume":"37","author":"Voltolini","year":"2010","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1097\/JTO.0b013e31827e1f83_bib33","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1002\/jso.21750","article-title":"Prognostic impact of local treatment against postoperative oligometastases in non-small cell lung cancer","volume":"102","author":"Yano","year":"2010","journal-title":"J Surg Oncol"},{"key":"10.1097\/JTO.0b013e31827e1f83_bib34","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0169-5002(02)00183-6","article-title":"A phase II trial of chemotherapy and surgery for non-small cell lung cancer patients with a synchronous solitary metastasis","volume":"38","author":"Downey","year":"2002","journal-title":"Lung Cancer"},{"issue":"suppl; abstr 7547","key":"10.1097\/JTO.0b013e31827e1f83_bib35","article-title":"Delay of chemotherapy through use of post-progression erlotinib in patients with EGFR-mutant lung cancer","volume":"30","author":"Oxnard","year":"2012","journal-title":"J Clin Oncol"},{"issue":"suppl; abstr 7572","key":"10.1097\/JTO.0b013e31827e1f83_bib36","article-title":"Treatment with EGFR tyrosine kinase inhibitors beyond progression in long-term responders to erlotinib in advanced non-small cell lung cancer: A case-control study of overall survival","volume":"30","author":"Faehling","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1097\/JTO.0b013e31827e1f83_bib37","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1097\/JTO.0b013e318160c607","article-title":"Prognostic and therapeutic implications of EGFR and KRAS mutations in resected lung adenocarcinoma","volume":"3","author":"Marks","year":"2008","journal-title":"J Thorac Oncol"},{"key":"10.1097\/JTO.0b013e31827e1f83_bib38","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1158\/1078-0432.CCR-10-2692","article-title":"Acquired resistance to EGFR tyrosine kinase inhibitors in EGFR-mutant lung cancer: distinct natural history of patients with tumors harboring the T790M mutation","volume":"17","author":"Oxnard","year":"2011","journal-title":"Clin Cancer Res"},{"key":"10.1097\/JTO.0b013e31827e1f83_bib39","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.1056\/NEJMoa061884","article-title":"Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer","volume":"355","author":"Sandler","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1097\/JTO.0b013e31827e1f83_bib40","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1056\/NEJMoa032975","article-title":"Preoperative PSA velocity and the risk of death from prostate cancer after radical prostatectomy","volume":"351","author":"D'Amico","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1097\/JTO.0b013e31827e1f83_bib41","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJMoa1113205","article-title":"Intratumor heterogeneity and branched evolution revealed by multiregion sequencing","volume":"366","author":"Gerlinger","year":"2012","journal-title":"N Engl J Med"},{"issue":"suppl; abstr 7529","key":"10.1097\/JTO.0b013e31827e1f83_bib42","article-title":"Concordance of driver mutations in primary and matched metastasis from patients with non-small cell lung cancer (NSCLC) using next-generation sequencing (NGS)","volume":"30","author":"Vignot","year":"2012","journal-title":"J Clin Oncol"}],"container-title":["Journal of Thoracic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1556086415327684?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1556086415327684?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,18]],"date-time":"2018-10-18T15:52:28Z","timestamp":1539877948000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1556086415327684"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3]]},"references-count":39,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["S1556086415327684"],"URL":"https:\/\/doi.org\/10.1097\/jto.0b013e31827e1f83","relation":{},"ISSN":["1556-0864"],"issn-type":[{"value":"1556-0864","type":"print"}],"subject":[],"published":{"date-parts":[[2013,3]]}}}